Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Cancer

Flavonoid consumption linked with reduced ovarian cancer risk

Consumption of flavonoids, which can be found in berries, linked to reduction of ovarian cancer risk, study finds

Source: Shutterstock.com

Consumption of flavonoids, which can be found in berries, has been linked to a reduction of ovarian cancer risk

Flavonoids are bioactive constituents of plants that are present in many foods and drinks. Analysis of a large US epidemiological dataset suggests that greater consumption of specific flavonoid subclasses may lower the risk of ovarian cancer.

Aedín Cassidy, from the University of East Anglia’s medical school, and colleagues from Harvard School of Public Health, Boston, analysed the diets of more than 170,000 women aged 25–55 years. In multivariate analyses, women with the highest dietary consumption of flavonols (found in tea, red wine, apples and grapes) and flavonones (found in citrus fruit and juices) had a lower risk of developing ovarian cancer than those with the lowest consumption.

Intake of total flavonoids and other subclasses were not associated with ovarian cancer risk, however, according to the research published in the American Journal of Clinical Nutrition (2014;100:1344–1351)[1].

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067094

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.